New Industry Forum to Advance Clinical Trial Participation
Kearney, Neb., June 13, 2017-In 2018, the Bridging Clinical Research and Clinical Health Care Collaborative will bring together industry leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups, and the FDA to advance the participation of patients and physicians in the conduct of clinical trials. The conference will be April 4–5 at the Gaylord National Resort and Conference Center in National Harbor, MD.
“Poor recruitment is the leading cause of failure in clinical trials. Less than 3 percent of patients and physicians participate,” said Cinda Orr, president and CEO of SCORR Marketing. “For quite some time, I have watched our industry try to determine how we can change this, but we have not made significant progress. As I am passionate about helping patients, I have established the Bridging Clinical Research and Clinical Health Care Collaborative with the support from health science colleagues and organizations so we can actualize a solution.”
The keynote speaker for the conference is Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Representing patients will be T.J. Sharpe, cancer survivor and patient advocate. Additional speakers have already been scheduled from 2bPrecise, Allscripts, HCA Healthcare, IBM Watson Health, INC Research and Sarah Cannon. Elligo Health Research, Allscripts, and INC Research are sponsors andApplied Clinical Trials, CenterWatch and FierceBiotech are media partners.
“This conference is at the core of what we do and we are proud to be a sponsor,” said John Potthoff, CEO at Elligo Health Research. “Just think what a significant impact we could make if we could get just an additional 3 percent of patients and physicians to participate. That would double the opportunity for patients to participate in clinical trials in the U.S.”
There are numerous ways to engage in the conference-attending, exhibiting, speaking or sponsoring. For more information on how to get involved, visit the website at www.bridgingclinical.com.
About Bridging Clinical Research and Clinical Health Care Collaborative
The Bridging Clinical Research and Clinical Health Care Collaborative is sponsored by SCORR Events, a division of SCORR Marketing, the leading marketing and communications firm in the health science industry. SCORR Events was established to provide education, collaboration and opportunities for industry professionals to advance health sciences.
CONTACT:
Lea Studer
SCORR Events
308-237-5567
lea@bridgingclinical.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
